TY - JOUR
T1 - Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity
T2 - A new source for graft facilitating cells in bone marrow transplantation
AU - Aviner, Shraga
AU - Yao, Xin
AU - Krauthgamer, Rita
AU - Gan, Yehudit
AU - Goren-Arbel, Rinat
AU - Klein, Tirza
AU - Tabilio, Antonio
AU - McMannis, John D.
AU - Champlin, Richard
AU - Martelli, Massimo F.
AU - Bachar-Lustig, Esther
AU - Reisner, Yair
PY - 2005/6/1
Y1 - 2005/6/1
N2 - Induction of donor type chimerism in mildly prepared hosts without graft-versus-host disease (GvHD) is a most desirable goal in bone morrow transplantation. We have recently demonstrated in a mouse model that donor veto cytotoxic T lymphocytes (CTLs) can facilitate the induction of donor type chimerism in sublethally irradiated recipients without causing GvHD if they are effectively depleted of alloreactivity against host cells by means of stimulation against a third party. We extend this approach to human cells, by preparing CTLs in two major steps: primary culture in the absence of interleukin 2, leading to death by neglect of antihost clones, and addition of interleukin 2 and subsequent dilution of antihost clones as a consequence of the expansion of the anti-third-party clones. CTLs prepared in this way specifically suppress host cytotoxic T cells directed against antigens of the donor, but not against fourth-party antigens, as demonstrated in a standard 51Cr release assay. We conclude that human anti-third-party CTLs afford a new source of veto cells that are depleted of potential graft-versus-host-reactive clones. The cells generated by this approach could potentially be used to facilitate engraftment of allogeneic hematopoietic stem cells.
AB - Induction of donor type chimerism in mildly prepared hosts without graft-versus-host disease (GvHD) is a most desirable goal in bone morrow transplantation. We have recently demonstrated in a mouse model that donor veto cytotoxic T lymphocytes (CTLs) can facilitate the induction of donor type chimerism in sublethally irradiated recipients without causing GvHD if they are effectively depleted of alloreactivity against host cells by means of stimulation against a third party. We extend this approach to human cells, by preparing CTLs in two major steps: primary culture in the absence of interleukin 2, leading to death by neglect of antihost clones, and addition of interleukin 2 and subsequent dilution of antihost clones as a consequence of the expansion of the anti-third-party clones. CTLs prepared in this way specifically suppress host cytotoxic T cells directed against antigens of the donor, but not against fourth-party antigens, as demonstrated in a standard 51Cr release assay. We conclude that human anti-third-party CTLs afford a new source of veto cells that are depleted of potential graft-versus-host-reactive clones. The cells generated by this approach could potentially be used to facilitate engraftment of allogeneic hematopoietic stem cells.
KW - Cytotoxic lymphocytes
KW - GvHD
UR - http://www.scopus.com/inward/record.url?scp=21544444739&partnerID=8YFLogxK
U2 - 10.1016/j.humimm.2005.03.004
DO - 10.1016/j.humimm.2005.03.004
M3 - Article
AN - SCOPUS:21544444739
SN - 0198-8859
VL - 66
SP - 644
EP - 652
JO - Human Immunology
JF - Human Immunology
IS - 6
ER -